Log in

Diagnostic interobserver variability in Crohn’s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Background

Crohn’s disease (CD) and ulcerative colitis, two forms of inflammatory bowel disease (IBD), are chronic and relapsing conditions of the gastrointestinal tract both characterized by long lasting chronic inflammation and increased risk of dysplasia and colorectal cancer (CRC). The aim of our study was to evaluate the interobserver agreement about IBD-associated dysplasia among pathologists belonging to the Italian Group for Inflammatory Bowel Diseases (IG-IBD P).

Methods

The present multicenter survey was performed using telepathology, supported by an open source E-learning platform. Biopsy specimens from 30 colonoscopies and from 20 patients were included. The glass slides of any case, including clinical and endoscopic data, were digitalized and uploaded on the E-learning platform. All the digital slides were grouped in 54 diagnostic “blocks”. Blinded histopathological evaluation on all the digital slides was performed by 20 gastrointestinal pathologists. Closed-ended questions about (1) the occurrence of IBD; (2) the classification of IBD (as UC or CD); (3) the presence of active versus quiescent disease; (4) the presence of dysplasia; (5) the possible association of dysplasia with the sites of disease (dysplasia-associated lesion or mass—DALM vs adenoma-like mass—ALM); (6) the grading of dysplasia according to the ECCO guidelines (negative, indefinite, low grade, high grade categories) and (7) the presence of associated serrated features, were proposed in each case. Inter-observer agreement was evaluated by mean agreement percentage and kappa statistic, when suitable.

Results

The diagnosis of IBD was confirmed in 19 of 20 patients, 17 of 19 being classified as UC, 2 as CD. The mean interobserver agreement percentages about (1) the evidence of IBD, (2) the presence of either UC or CD and (3) the activity grading resulted to be 80%, 69% and 86%, respectively. Dysplasia was detected in 8/20 patients, with moderate agreement between pathologists (mean 72%, k 0.48). Particularly, low grade dysplasia was found in 13 biopsies (combined k 0.38), whereas high grade dysplasia in 8 (combined k 0.47). When the endoscopic and histopathological data were combined, features consistent with DALM were found in 6 of 20 patients with low grade dysplasia and those consistent with ALM in 2 patients with low grade dysplasia in a single biopsy (mean agreement: 86%). An associated serrated pattern was discovered in 4 patients (7 biopsies).

Conclusions

Our study showed moderate interobserver agreement about the histopathological detection and classification of IBD-associated dysplasia. Further efforts should be undertaken to integrate the histopathological data with both the ancillary tests and molecular investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time. Based Syst Rev Gastroenterol 142(1):46–54

    Google Scholar 

  2. Feuerstein JD, Cheifetz AS (2014) Ulcerative colitis: epidemiology, diagnosis, and management review. Mayo Clin Proc 89(11):1553–1563

    Article  Google Scholar 

  3. Ananthakrishnan AN (2015) Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60(2):290–298

    Article  CAS  Google Scholar 

  4. Lee D, Albenberg L, Compher C et al (2015) Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 148(6):1087–1106

    Article  CAS  Google Scholar 

  5. Jess T, Simonsen J, Jørgensen KT et al (2012) Decreasing risk of colorectal cancer in patients with IBD over 30 years. Gastroenterology 143(2):375–381

    Article  Google Scholar 

  6. Herrinton LJ, Liu L, Levin TR et al (2012) Incidence and mortality of colorectal adenocarcinoma in persons with IBD from 1998 to 2010. Gastroenterology 143:382–389

    Article  Google Scholar 

  7. De Jong ME, Kanne H, Nissen LHC et al (2020) Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia. Gastrointest Endosc 91(6):1334–1342.e1

    Article  Google Scholar 

  8. Zhang YZ, Li YY (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20(1):91–99

    Article  Google Scholar 

  9. Quetglas EG, Mujagic Z, Wigge S et al (2015) Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol 21(44):12519–12543

    Article  CAS  Google Scholar 

  10. Beaugerie L, Itzkowitz SH (2015) Cancers complicating inflammatory bowel disease. Rev N Engl J Med 372(15):1441–1452

    Article  CAS  Google Scholar 

  11. Svrcek M, Borralho Nunes P, Villanacci V et al (2018) Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: the role of inflammation. J Crohns Colitis 12(12):1486–1498

    PubMed  Google Scholar 

  12. Laine L, Kaltenbach T, Barkun A et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81(3):489–501

    Article  Google Scholar 

  13. Magro F, Langner C, Driessen A et al (2013) European consensus on the histopathology of IBD. J Crohns Colitis 7(10):827–851

    Article  CAS  Google Scholar 

  14. Schlemper RJ, Riddell RH, Kato Y et al (2000) The vienna classification of gastrointestinal epithelial neoplasia. Gut 47(2):251–255

    Article  CAS  Google Scholar 

  15. Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931–968

    Article  CAS  Google Scholar 

  16. Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11(1):3–25

    Article  Google Scholar 

  17. Feakins RM, British Society of Gastroenterology (2013) IBD biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol 66(12):1005–1026

    Article  Google Scholar 

  18. Harpaz N, Polydorides AD (2010) Colorectal dysplasia in chronic IBD: pathology, clinical implications, and pathogenesis. Arch Pathol Lab Med 134(6):876–895

    PubMed  Google Scholar 

  19. Bressenot A, Cahn V, Danese S et al (2014) Microscopic features of colorectal neoplasia in IBDs. World J Gastroenterol 20(12):3164–3172

    Article  Google Scholar 

  20. Odze RD (2006) Pathology of dysplasia and cancer in IBD. Gastroenterol Clin N Am 35(3):533–552

    Article  Google Scholar 

  21. Bossard C, Denis MG, Bézieau S et al (2007) Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 18(5):1093–1097

    PubMed  Google Scholar 

  22. Srivastava A, Redston M, Farraye FA et al (2008) Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 32(2):296–303

    Article  Google Scholar 

  23. Jackson WE, Achkar JP, Macaron C et al (2016) The significance of sessile serrated polyps in inflammatory bowel disease. Inflamm Bowel Dis 22(9):2213–2220

    Article  Google Scholar 

  24. Fleiss J (1981) Statistical methods for rates and proportions. Wiley, New York, p 13

    Google Scholar 

  25. Landis J, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  CAS  Google Scholar 

  26. Altman D (1991) Practical statistics for medical research. Chapman and Hall, London

    Google Scholar 

  27. Feinstein AR, Cicchetti DV (1990) High agreement but low kappa: the problems of two paradoxes. J Clin Epidemiol 43(6):543–549

    Article  CAS  Google Scholar 

  28. Cicchetti DV, Feinstein AR (1990) High agreement but low Kappa: II. Resolving the paradoxes. J Clin Epidemiol 43(6):551–558

    Article  CAS  Google Scholar 

  29. Eaden J, Abrams K, McKay H et al (2001) Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 194(2):152–157

    Article  CAS  Google Scholar 

  30. Allende D, Elmessiry M, Hao W et al (2014) Inter-observer and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings [published correction appears in Colorectal Dis. 2015;17(1):92. Al-Qadasi, M [added]]. Colorectal Dis 16(9):710–718

    Article  CAS  Google Scholar 

  31. Odze RD, Goldblum J, Noffsinger A et al (2002) Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 15(4):379–386

    Article  Google Scholar 

  32. Odze RD, Tomaszewski JE, Furth EE et al (2006) Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 16(5):1123–1129

    PubMed  Google Scholar 

  33. Wu XR, Liu HS, Shi XY et al (2018) Interobserver agreement in the diagnosis of inflammatory bowel disease-associated neoplasia in China in comparison to subspecialized American Gastrointestinal Pathologists. Gastroenterol Res Pract 2018:8715263

    Article  Google Scholar 

  34. Van der Wel MJ, Coleman HG, Bergman JJGHM et al (2020) Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett’s dysplasia using digital pathology. Gut 69(5):811–822

    Article  Google Scholar 

  35. Weinstein RS, Bhattacharyya AK, Graham AR et al (1997) Telepathology: a ten-year progress report. Hum Pathol 28:1–7

    Article  CAS  Google Scholar 

  36. Villanacci V, Baronchelli C, Manenti S et al (2019) Serrated lesions of the colon. A window on a more clear classification. Ann Diagn Pathol 41:8–13

    Article  Google Scholar 

Download references

Acknowledgements

The Authors thank Bio-Optica—Milan—for technical support. L. Albarello: Institute of Pathology San Raffaele Hospital Milan, Italy; albarello.luca@hsr.it, A. Andorno: Institute of Pathology Ospedale Maggiore Novara, Italy; lisa@wolfman.it, M. R. Aprile: Institute of Pathology S.Maria delle Croci Hospital Ravenna, Italy; mariarosaria.aprile@auslromagna.it, M. C. Aquilano: Institute of Pathology ASST Niguarda Milan, Italy; mariacostanza.aquilano@ospedaleniguarda.it, L. Baron: Institute of Pathology San Leonardo Hospital ASL Napoli 3 Sud, Italy; anapat1@libero.it, S. Battista: Institute of Pathology S.Maria della Misericordia Hospital Udine, Italy; serena.battista@asuiud.sanita.fvg.it, G. Becchina: UOC Institute of Pathology Palermo Hospital, Italy; gbecchina@hotmail.com, D. Bellis: Institute of Pathology ASL Biella, Italy; donata.bellis@libero.it, E. Biletta: Institute of Pathology ASL Biella, Italy; elena.biletta@gmail.com. M. R. D’Ambrosio: UOC Anatomia Patologica Dip Biotecnologie University of Siena, Italy; maradot@libero.it, E. David: Institute of Pathology, University of Turin, Italy; ezio.david@unito.it, R. Del Sordo: Institute of Pathology S.Maria della Misericordia Hospital Perugia, Italy; rachele.delsordo@unipg.it,M. Facchetti: Institute of Pathology Spedali Civili Brescia, Italy; facchetti.m@gmail.com, M. Fortunato: Institute of Pathology S. Croce e Carle Hospital Cuneo, Italy; mirellafortunato@hotmail.com, M. C. Giustiniani: Institute of Pathology Fondazione Policlinico Gemelli Roma, Italy; giustiniani@policlinicogemelli.it, D. Piscitelli: Institute of Pathology Policlinico Bari, Italy; domenico.piscitelli@uniba.it, L. Saragoni: Institute of Pathology Ospedale Morgagni-Pierantoni Forlì, Italy; luca.saragoni@auslromagna.it, G. Tanzi: Institute of Pathology ASST Cremona, Italy; giuliapaola.gt@libero.it.

Funding

The authors study has not been supported by any source of funding.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

VV contributed to the study conception. The study design was performed by GL, VV and GC. Data collection and analysis were performed by GC, GL, FD, LR-B, TS, MC, IG-IBD pathologists as collaborators (see “Acknowledgements”). The first draft was written by GL. Critical revisions were performed by FD, VV, AA, MBP, MD, FC. The final editing was performed by GL. The manuscript was finally approved by all the authors and then submitted by GL.

Corresponding author

Correspondence to G. Leoncini.

Ethics declarations

Conflict of interest

The authors have not any conflict of interest to declare.

Ethical approval

The author survey was based on diagnostic glass slides digital scanning and examination, human participants and/or animals were not involved.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The collaborators are listed in Acknowledgements.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leoncini, G., Donato, F., Reggiani-Bonetti, L. et al. Diagnostic interobserver variability in Crohn’s disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group. Tech Coloproctol 25, 101–108 (2021). https://doi.org/10.1007/s10151-020-02349-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-020-02349-9

Keywords

Navigation